Teijin Launches Somatuline Injection For Acromegaly Treatment
This article was originally published in PharmAsia News
Executive Summary
Teijin Pharma has launched Somatuline subcutaneous injection (lanreotide acetate) for the treatment of acromegaly and pituitary gigantism, the company announced Jan. 17